162 related articles for article (PubMed ID: 1690184)
1. Biodistribution and magnetic resonance imaging of cross-linked DTPA polysaccharides.
Gibby WA; Billings J; Hall J; Ovitt TW
Invest Radiol; 1990 Feb; 25(2):164-72. PubMed ID: 1690184
[TBL] [Abstract][Full Text] [Related]
2. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
3. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
4. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride.
Dean PB; Niemi P; Kivisaari L; Kormano M
Invest Radiol; 1988 Sep; 23 Suppl 1():S258-60. PubMed ID: 3198357
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Press WR; Weinmann HJ
Invest Radiol; 1991 Nov; 26(11):969-74. PubMed ID: 1743920
[TBL] [Abstract][Full Text] [Related]
9. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
10. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.
Wang SC; Wikström MG; White DL; Klaveness J; Holtz E; Rongved P; Moseley ME; Brasch RC
Radiology; 1990 May; 175(2):483-8. PubMed ID: 1691513
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and clearance of liposomal gadolinium-DTPA.
Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
[TBL] [Abstract][Full Text] [Related]
13. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
14. Quantification of tissue gadolinium concentration using magnetic resonance imaging: comparison of ultrashort inversion time inversion recovery echoplanar and dynamic three-dimensional spoiled gradient-recalled approaches with in vitro measurements.
Roberts TP; Brasch RC; Schwickert HC; Shames DM; vanDijke CF; Stiskal M; Mann JS; Mühler A; Demsar F
Acad Radiol; 1996 Aug; 3 Suppl 2():S282-5. PubMed ID: 8796581
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
[TBL] [Abstract][Full Text] [Related]
16. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis.
Fujita M; Yamamoto R; Takahashi M; Tsuji T; Yamanaka T; Miyazawa T; Fritz-Zieroth B; Terada N; Kuroda C
J Magn Reson Imaging; 1997; 7(4):768-70. PubMed ID: 9243401
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: targeted MRI contrast enhancement agents for the liver.
Kabalka GW; Davis MA; Moss TH; Buonocore E; Hubner K; Holmberg E; Maruyama K; Huang L
Magn Reson Med; 1991 Jun; 19(2):406-15. PubMed ID: 1881329
[TBL] [Abstract][Full Text] [Related]
18. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent.
Niemi P; Koskinen S; Reisto T
Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276
[TBL] [Abstract][Full Text] [Related]
19. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool and perfusion imaging.
Schmiedl U; Brasch RC; Ogan MD; Moseley ME
Acta Radiol Suppl; 1990; 374():99-102. PubMed ID: 1966977
[TBL] [Abstract][Full Text] [Related]
20. Cross-linked DTPA polysaccharides for magnetic resonance imaging. Synthesis and relaxation properties.
Gibby WA; Bogdan A; Ovitt TW
Invest Radiol; 1989 Apr; 24(4):302-9. PubMed ID: 2745011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
